These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Interview: partnering with the industry: the Olympic laboratory model. Cowan DA; Barker CP Bioanalysis; 2012 Jul; 4(13):1545-8. PubMed ID: 22831471 [TBL] [Abstract][Full Text] [Related]
26. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances. Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541 [TBL] [Abstract][Full Text] [Related]
27. A global strategy for prevention and detection of blood doping with erythropoietin and related drugs. Cazzola M Haematologica; 2000 Jun; 85(6):561-3. PubMed ID: 10870110 [No Abstract] [Full Text] [Related]
28. Development of the role of national anti-doping organisations in the fight against doping: from past to future. Kamber M Forensic Sci Int; 2011 Dec; 213(1-3):3-9. PubMed ID: 21835566 [TBL] [Abstract][Full Text] [Related]
30. The worldwide fight against doping: from the beginning to the World Anti-Doping Agency. Kamber M; Mullis PE Endocrinol Metab Clin North Am; 2010 Mar; 39(1):1-9, vii. PubMed ID: 20122445 [TBL] [Abstract][Full Text] [Related]
31. [Doping is serious cheating--and the destiny issue of sports. The modern anti-doping work began in 1961]. Ljungqvist A Lakartidningen; 2012 Jul 18-Aug 8; 109(29-31):1337-8. PubMed ID: 22913112 [No Abstract] [Full Text] [Related]
32. Doping is a threat to sporting excellence. Devine JW Br J Sports Med; 2011 Jun; 45(8):637-9. PubMed ID: 20542968 [TBL] [Abstract][Full Text] [Related]
33. Make Sport Great Again: The Use and Abuse of the Therapeutic Use Exemptions Process. Pitsiladis Y; Wang G; Lacoste A; Schneider C; Smith AD; Di Gianfrancesco A; Pigozzi F Curr Sports Med Rep; 2017; 16(3):123-125. PubMed ID: 28498217 [No Abstract] [Full Text] [Related]
34. Structure and Development of the List of Prohibited Substances and Methods. Kinahan A; Budgett R; Mazzoni I Med Sport Sci; 2017; 62():39-54. PubMed ID: 28571027 [TBL] [Abstract][Full Text] [Related]
35. The faking of champions. DeFrancesco L Nat Biotechnol; 2004 Sep; 22(9):1069-71. PubMed ID: 15340461 [No Abstract] [Full Text] [Related]
36. Glucocorticoids in elite sport: current status, controversies and innovative management strategies-a narrative review. Vernec A; Slack A; Harcourt PR; Budgett R; Duclos M; Kinahan A; Mjøsund K; Strasburger CJ Br J Sports Med; 2020 Jan; 54(1):8-12. PubMed ID: 31326919 [TBL] [Abstract][Full Text] [Related]
37. The doping dilemma. Shermer M Sci Am; 2008 Apr; 298(4):82-9. PubMed ID: 18380145 [No Abstract] [Full Text] [Related]
38. Opinion paper: scientific, philosophical and legal consideration of doping in sports. Negro M; Marzullo N; Caso F; Calanni L; D'Antona G Eur J Appl Physiol; 2018 Apr; 118(4):729-736. PubMed ID: 29427238 [TBL] [Abstract][Full Text] [Related]
39. New IOC Certificate in Drugs in Sport supports healthcare professionals to lead on effective clinical drug use and doping prevention in athletes. Stuart M; Mottram D Br J Sports Med; 2019 Jan; 53(1):48-49. PubMed ID: 30504487 [No Abstract] [Full Text] [Related]
40. Ensuring high quality in anti-doping laboratories. Boghosian T; Barroso O; Ivanova V; Rabin O Bioanalysis; 2012 Jul; 4(13):1591-601. PubMed ID: 22831475 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]